Regulus Therapeutics
RGLS
#8238
Rank
S$0.24 B
Marketcap
$3.68
Share price
9.80%
Change (1 day)
21.86%
Change (1 year)

Earnings for Regulus Therapeutics (RGLS)

Earnings in 2024 (TTM): -S$61.58 Million

According to Regulus Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -S$38.71 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regulus Therapeutics from 2012 to 2024

Annual earnings

Year Earnings Change
2024 -S$60.76 Million56.97%
2023 -S$38.71 Million6.51%
2022 -S$36.35 Million2.53%
2021 -S$35.45 Million93.59%
2020 -S$18.31 Million-15.41%
2019 -S$21.65 Million-64.46%
2018 -S$60.9 Million-33.26%
2017 -S$91.25 Million-13.98%
2016 -S$0.11 Billion44.77%
2015 -S$73.28 Million-1.63%
2014 -S$74.49 Million203.6%
2013 -S$24.54 Million8.65%
2012 -S$22.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$5.77 B-9,611.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$10.44 B-17,290.56%๐Ÿ‡ซ๐Ÿ‡ท France
S$2.50 B-4,225.54%๐Ÿ‡บ๐Ÿ‡ธ USA
S$13.72 B-22,682.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
-S$0.31 Billion 409.78%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.13 Billion 113.09%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$11.02 Billion 18,036.36%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.16 Billion 154.66%๐Ÿ‡บ๐Ÿ‡ธ USA